Boehringer Ingelheim registers study of survodutide in overweight or obesity without diabetes
This study was first posted on ClinicalTrials.gov on October 2, 2026. The Phase IIIb, open-label study plans to enroll 350 participants, with a planned start date of November 7, 2026 and a primary completion date of June 25, 2028.
Primary source
ClinicalTrials.gov registry record, October 2, 2026
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Read the source: SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation